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Abstract
Pathogens target important components of host immunity to
cause disease. The Pseudomonas syringae type III-secreted
effector HopU1 is a mono-ADP-ribosyltransferase required for
full virulence on Arabidopsis thaliana. HopU1 targets several
RNA-binding proteins including GRP7, whose role in immunity is
still unclear. Here, we show that GRP7 associates with
translational components, as well as with the pattern recognition
receptors FLS2 and EFR. Moreover, GRP7 binds specifically
FLS2 and EFR transcripts in vivo through its RNA recognition
motif. HopU1 does not affect the protein–protein associations
between GRP7, FLS2 and translational components. Instead,
HopU1 blocks the interaction between GRP7 and FLS2 and
EFR transcripts in vivo. This inhibition correlates with reduced
FLS2 protein levels upon Pseudomonas infection in a HopU1dependent manner. Our results reveal a novel virulence strategy
used by a microbial effector to interfere with host immunity.

Pseudomonas HopU1 modulates plant immune
receptor levels by blocking the interaction of
their mRNAs with GRP7
The Pseudomonas virulence factor HopU1 mono-ADPribosylates the plant RNA-binding protein GRP7 protein to inhibit
its binding to immune receptor mRNAs, leading to the
suppression of receptor protein synthesis and hence host
immunity.

Introduction
An important aspect of innate immunity is the perception of pathogenassociated molecular patterns (PAMPs) by specific pattern recognition
2

receptors (PRRs) leading to PAMP-triggered immunity (PTI; Dodds and
Rathjen, 2010; Segonzac and Zipfel, 2011). In Arabidopsis thaliana, the
leucine-rich repeat receptor kinases (LRR-RKs) FLS2 and EFR recognize
bacterial flagellin (or its derived peptide flg22) and EF-Tu (or its derived
peptide elf18), respectively (Gomez-Gomez and Boller, 2000; Zipfel et al,
2006), while perception of fungal chitin depends on the LysM-RK CERK1
(Miya et al, 2007; Wan et al, 2008). In addition to its role in chitin
perception, CERK1 is required for peptidoglycan perception (Willmann et
al, 2011). Perception of flg22, elf18 or chitin induces a series of early
immune responses, including a rapid burst of reactive oxygen species
(ROS), phosphorylation events, gene expression, as well as late responses
such as callose deposition at the plant cell wall and resistance to pathogens
(Segonzac and Zipfel, 2011). Plant PRRs are key to immunity, as their
inhibition or loss of function leads to enhanced susceptibility to adapted and
non-adapted pathogens (Segonzac and Zipfel, 2011; Willmann et al, 2011).
Pathogens must block or avoid PTI to cause disease. A potent strategy to
inhibit PTI is via the action of secreted effectors delivered into the host cells
leading to effector-triggered susceptibility (ETS; Dodds and Rathjen, 2010).
The genome of the phytopathogenic bacterium Pseudomonas syringae pv.
tomato DC3000 (Pto DC3000) encodes >30 type III-secreted effectors
(T3SEs). Recently, several T3SEs from different P. syringae strains were
shown to be virulence factors. Corresponding host targets have been
identified only for a few of them, but they revealed that T3SEs interfere
with key components of PTI (Block and Alfano, 2011). For instance, AvrPto
is a kinase inhibitor that blocks PTI signalling by interfering with the
activation of PRRs and/or the complex formation of PRRs with their
associated proteins (Xing et al, 2007; Shan et al, 2008; Xiang et al, 2008,
2011). AvrPtoB is a multifunctional protein carrying E3 ubiquitin ligase
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activity that leads to the degradation of several PRRs and the inhibition of
the PRR-associated LRR-RK BAK1 (Gohre et al, 2008; Shan et al, 2008;
Gimenez-Ibanez et al, 2009; Cheng et al, 2011; Zeng et al, 2012). Other Pto
DC3000 T3SEs target signalling components downstream of PRR activation
(Block and Alfano, 2011; Feng et al, 2012).
The Pto DC3000 T3SE HopU1 is a mono-ADP-ribosyltransferase (monoADP-RT) required for full virulence in Arabidopsis (Fu et al, 2007). Ectopic
expression of HopU1 in A. thaliana suppresses callose deposition induced
by flg22 in a manner dependent on its mono-ADP-RT activity (Fu et al,
2007). HopU1 targets at least five different A. thaliana RNA-binding
proteins (RBPs), including Glycine-Rich Protein 7 (GRP7) and GRP8 (Fu et
al, 2007). HopU1 mono-ADP-ribosylates an arginine at position 49 (R49)
located in the conserved ribonucleoprotein consensus sequence 1 (RNP-1)
motif of the RNA recognition motif (RRM) of GRP7, and this modification
affects GRP7's ability to bind RNA in vitro (Jeong et al, 2011). Although
HopU1 targets several RBPs, grp7 null mutant plants produce less ROS and
callose in response to flg22, elf18 and chitin (Fu et al, 2007; Jeong et al,
2011), indicating that GRP7 regulates both early and late PAMP responses.
In addition, grp7 plants are more susceptible to Pto DC3000 (Fu et al, 2007;
Jeong et al, 2011). A mutation in R49 blocks the ability of GRP7 to
complement these phenotypes (Jeong et al, 2011). These results demonstrate
the importance of GRP7 in plant innate immunity and the potency of monoADP-ribosylation to block GRP7 function. However, as in the case for many
targets of pathogenic effectors, the exact role of GRP7 in innate immunity
and therefore the molecular mechanism underlying PTI suppression by
HopU1 are still unclear.
Here, we illustrate a function for GRP7 in PTI that is inhibited by HopU1.
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We show that GRP7 associates with translational components in vivo, and
more surprisingly that GRP7 associates with the PRRs FLS2 and EFR.
However, HopU1 does not affect the associations between GRP7, FLS2 and
translational components. Instead, we reveal that GRP7 binds FLS2 and EFR
mRNA in vivo, and that HopU1 blocks this interaction. The FLS2 and EFR
transcripts provide the first examples of in vivo targets for GRP7 with a
clear biological function. This inhibition correlates with reduced FLS2
protein levels in planta upon infection with Pto DC3000 in a HopU1dependent manner. Our results reveal a novel virulence strategy used by a
microbial effector to interfere with host immunity.

Results
Modulation of GRP7 level and activity affects early and late immune
responses
Previous results conclusively showed that loss of GRP7 impairs PTI and
resistance to Pto DC3000 infection (Fu et al, 2007; Jeong et al, 2011). To
investigate the consequences of ectopic GRP7 expression, we monitored PTI
and pathogen response in transgenic A. thaliana plants expressing untagged
GRP7 under the control of the constitutive promoter 35S (GRP7ox lines)
(Streitner et al, 2008). An immunoblot analysis using a specific anti-GRP7
antibody confirmed higher GRP7 levels in transgenic homozygous GRP7ox
plants in comparison to the wild-type (WT) Col-2 ecotype (Supplementary
Figure S1). A. thaliana Col-2 (WT) and GRP7ox plants were treated with
flg22, elf18 or chitin, which resulted in substantially higher ROS production
in GRP7ox plants compared to WT (Figure 1A). Similarly, callose
deposition was increased in GRP7ox plants compared to WT plants after all
three treatments (Figure 1B).
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The A. thaliana GRP7ox plants were used in pathogenicity assays with Pto
DC3000 or the Pto DC3000 hrcC− mutant that does not secrete any T3SEs
and is therefore severely hypo-virulent. Plants were spray inoculated and
bacteria were enumerated at 0 and 4 days after inoculation. Interestingly,
GRP7ox plants were more resistant to infection by Pto DC3000 than WT
plants (Figures 1C and D). The Pto DC3000 hrcC− mutant exhibited
unaltered growth on GRP7ox plants. This may be due to the strongly
reduced virulence of the Pto DC3000 hrcC− mutant to which the
endogenous GRP7 seems to be sufficient to confer high resistance. The
increased resistance to Pto DC3000 infection observed in plants
overexpressing GRP7 clearly demonstrates its important role in innate
immunity.
GRP7 is required for full immunity to Pto DC3000 WT and hrcC−, and
HopU1 targets GRP7 (Fu et al, 2007; Jeong et al, 2011). To assess the extent
to which HopU1 inhibits PTI responses, we analysed early and late
responses triggered by flg22 in transgenic A. thaliana lines constitutively
expressing HopU1 C-terminally tagged with haemagglutinin (HA) under the
control of the 35S promoter (Fu et al, 2007). In HopU1 plants, the ROS burst
induced by flg22 and elf18 treatment was reduced compared to WT plants
(Supplementary Figure S2A). Next, we confirmed that HopU1 leaves exhibit
less callose deposition upon flg22 treatment (Supplementary Figure S2B; Fu
et al, 2007). The reduced flg22 responsiveness of the HopU1 plants
correlated with reduced FLS2 protein levels observed in three out of four
independent biological experiments (Supplementary Figure S2C). These
results were further validated using A. thaliana transgenic lines expressing
HopU1-HA under the control of an estradiol-inducible promoter
(ind_HopU1) (Supplementary Figures S2D and E). Together, this
6

demonstrates that HopU1 affects both early and late flg22-induced
responses.
To test whether in planta HopU1 expression affects A. thaliana disease
resistance, we assayed bacterial growth after spray inoculation with the Pto
DC3000 strains WT, hrcC− or ΔhopU1 that is hypo-virulent (Fu et al, 2007).
HopU1 plants were more susceptible to all the strains tested (Supplementary
Figure S2F), albeit to a lesser extent than fls2 null mutant plants consistent
with the reduced flg22 sensitivity of HopU1 plants (Supplementary Figures
S2A–E). Consistent with the notion that GRP7 is a main target of HopU1 in
reducing plant immunity, GRP7ox plants were as resistant to Pto DC3000 as
WT plants to Pto DC3000 ΔhopU1 (Supplementary Figure S2G). These
results, together with previous results (Fu et al, 2007; Jeong et al, 2011),
indicate that the abundance and/or activity of GRP7 are both required and
limited for triggering optimal early and late PTI responses.

GRP7 associates with the immune receptors FLS2 and EFR at the
plasma membrane
The importance of GRP7 for early PTI responses suggests that GRP7 may
affect directly PRRs and/or associated proteins, or indirectly the expression
and/or biogenesis of such proteins.
Notably, we identified GRP7 in an unbiased yeast two-hybrid screen for
EFR-interacting proteins (Supplementary Figure S3A). Importantly, we
could confirm this interaction in co-immunoprecipitation experiments after
transient co-expression of EFR and GRP7 as C-terminally tagged fusion
proteins with HA and enhanced green fluorescent protein (GFP) tags (EFR-3
× HA and GRP7-eGFP, respectively) in Nicotiana benthamiana (Figure 2A).
Similarly, GRP7 and FLS2 also interacted when transiently co-expressed as
7

fusion proteins (FLS2-3 × myc and GRP7-eGFP) in N. benthamiana (Figure
2B). However, GRP7-eGFP did not interact under similar conditions with
the LRR-RK BAK1 (BAK1-HA) (Figure 2C), which is an important positive
regulator of PTI responses downstream of FLS2 and EFR (Chinchilla et al,
2007; Heese et al, 2007; Roux et al, 2011).
We confirmed the GRP7–FLS2 association by co-immunoprecipitation in an
A. thaliana transgenic line expressing GRP7 C-terminally tagged with a GFP
epitope (GRP7-GFP) under the control of the 35S promoter (Kim et al,
2008) and using an anti-FLS2 antibody recognizing the native FLS2 protein
(Figure 2D). The GRP7–FLS2 interaction occurred independently of
elicitation and was unaltered by flg22 treatment (Figure 2D). The presence
of EFR and FLS2 proteins that may correspond to their glycosylated forms
(migrating at ∼150 kDa and ∼175 kDa, respectively Nekrasov et al, 2009;
Haweker et al, 2010) in the GRP7 immunoprecipitates (Figures 2A, B and
D) suggests that the association between GRP7 and PRRs occurs at the
plasma membrane once the mature and functional PRRs have migrated
through the secretory pathway.
GRP7-GFP shows a nucleo-cytoplasmic subcellular localization in A.
thaliana, tobacco (Nicotiana tabacum) and N. benthamiana cells upon stable
or transient expression (Supplementary Figures S4A and B; Ziemienowicz
et al, 2003; Fu et al, 2007; Kim et al, 2008; Lummer et al, 2011).
Bimolecular fluorescence complementation (BiFC) experiments using splityellow fluorescent protein (YFP) following transient expression in N.
benthamiana suggest that GRP7 and FLS2 closely associate (Figure 2E).
This interaction occurs most likely at the plasma membrane, as indicated by
the presence of the reconstituted YFP signal in typical cell wall–plasma
membrane connections (called Hechtian strands) after cell plasmolysis
8

(arrows in Figure 2E). An interaction at the cell periphery between GRP7
and EFR could also be observed (Supplementary Figure S3B).

GRP7 associates with translational components
In exploratory experiments to identify GRP7 interactors in planta by
immunoprecipitation using an A. thaliana transgenic line expressing GRP7
C-terminally tagged with HA under the control of its native promoter
(GRP7-HA) (Jeong et al, 2011), we identified by mass-spectrometry
analysis of the GRP7-HA immunoprecipitates several components of the
43S complex involved in protein translation (Supplementary Table S1).
Before the initiation of active translation, the 43S complex recruits both
mRNAs and ribosomes, and is composed of several initiation factors in
addition to the cap-binding protein eIF4E and the ribosomal 40S subunit
(Pestova et al, 2001).
Co-immunoprecipitation experiments using the A. thaliana GRP7-GFP
transgenic line (Kim et al, 2008) and specific antibodies further revealed the
presence of eIF4E and the ribosomal subunit S14 in complex with GRP7
(Figure 3). We used here the GRP7-GFP line for consistency with previous
targeted co-immunoprecipitation experiments (Figure 2). Interestingly,
slower migrating bands of eIF4E were enriched in GRP7-GFP
immunoprecipitates in comparison to the main form detected in the input
(see asterisks in Figure 3). Strikingly, treatment with flg22 induced the
dissociation of elF4E and S14 from the GRP7 complex (Figure 3),
indicating a potential dynamic link between GRP7, ligand-activated PRRs
and components of the translational machinery.

HopU1 does not affect interactions between GRP7, PRRs and
translational components
9

Next, we tested if HopU1 could directly affect FLS2 or the GRP7–FLS2
interaction. HopU1 did not interact with FLS2 in vivo as determined by coimmunoprecipitation and split-YFP experiments in N. benthamiana
(Supplementary Figures S5A and B). Consistently, HopU1 did not monoADP-ribosylate FLS2 in vitro (Supplementary Figure S5C).
Although HopU1 directly interacts with GRP7 in vivo (Supplementary
Figure S6), HopU1 did not affect the interaction between GRP7 and FLS2 in
an A. thaliana transgenic line expressing both GRP7-GFP and HopU1-HA
(Figure 4). In addition, HopU1 did not interfere, at least qualitatively, with
the association or ligand-induced dissociation between GRP7-GFP and
either elF4E or S14 (Supplementary Figure S7). Therefore, the effect of
HopU1 on PTI responses is most likely not mediated by direct inhibition of
PRRs or protein–protein interactions with GRP7.

GRP7 associates with FLS2 and EFR transcripts in planta
Next, we investigated the role of GRP7 in PTI in relation to its capacity to
bind RNA by testing if GRP7 could bind PRR transcripts. Quantitative
RNA-immunoprecipitation assays using the A. thaliana GRP7-HA (Jeong et
al, 2011) transgenic line revealed that GRP7 binds FLS2 mRNAs in vivo
independently of flg22 treatment (Figure 5A). As positive controls, we
confirmed that GRP7 binds its own transcripts as well as transcripts of its
closest paralogue GRP8 (Figure 5A), as previously reported in vitro (Staiger
et al, 2003; Schoning et al, 2008). GRP7 binds the 3′-UTR of its own
transcript and of the GRP8 mRNA (Schoning et al, 2007). Similarly, we
identified the 3′-UTR as a binding region of GRP7 in the FLS2 mRNA
(Figures 5B and C). In addition to the FLS2 mRNA, GRP7 could also bind
the EFR transcript in vivo (Supplementary Figure S8A), consistent with the
importance of GRP7 for responses triggered by both flg22 and elf18 (Jeong
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et al, 2011; Figure 1). However, transcripts of the regulatory LRR-RK BAK1
were not enriched in GRP7 immunoprecipitates (Figure 5A; Supplementary
Figure S8A), revealing a certain degree of specificity. Interestingly, GRP8,
which is also targeted by HopU1 (Fu et al, 2007), is also able to bind FLS2
and EFR mRNAs (Supplementary Figure S9). These results demonstrate that
GRP7, as well as GRP8, bind transcripts of the important PRRs FLS2 and
EFR.

HopU1 disrupts the association between GRP7 and PRR transcripts
Next, we investigated if HopU1 could affect the ability of GRP7 to bind its
target mRNAs, including FLS2 and EFR transcripts. Using an A. thaliana
transgenic line expressing both GRP7-GFP and HopU1-HA in quantitative
RNA-immunoprecipitation assays, we found that the amount of FLS2 and
EFR transcripts bound to GRP7-GFP was strongly reduced in the presence
of HopU1 (Figure 6A; Supplementary Figure S8A). A similar effect was
observed on the interaction between GRP7 and its own mRNA (Figure 6A;
Supplementary Figure S8A). Furthermore, a GRP7(R49K) variant, which
carries a mutation in a conserved arginine residue within the RRM RNAbinding domain that is mono-ADP-ribosylated by HopU1 (Jeong et al,
2011), is strongly impaired in its ability to bind FLS2, EFR, GRP7 and
GRP8 transcripts (Figure 6B; Supplementary Figure S8B). Furthermore,
ADP ribosylation of GRP7 by HopU1 (but not by the catalytically inactive
HopU1DD variant; Fu et al, 2007; Jeong et al, 2011) completely blocks the
binding of GRP7 to the 3′-UTR of FLS2 mRNA in vitro (Figure 6C).
Together, our results suggest that the mono-ADP ribosylation of GRP7 by
HopU1 disrupts in planta the ability of GRP7 to bind mRNAs of the PRRs
FLS2 and EFR.

HopU1 inhibits the pathogen-induced FLS2 protein accumulation
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during Pseudomonas infection
Because HopU1 inhibits GRP7–FLS2 mRNA binding (Figure 6), we asked
whether HopU1's action could ultimately affect FLS2 protein levels after
translocation into A. thaliana cells during Pto DC3000 infection, which
would correspond to the most biologically relevant observation. We
observed that the amount of FLS2 protein increases (3.5- to 3.8-fold) over
24 h in leaves infected with Pto DC3000 hrcC− (unable to secrete any T3SEs
and therefore unable to dampen PTI) (Figure 7A), consistent with the
previous observation that the expression of FLS2, EFR and other potential
PRR-encoding genes is PAMP inducible (Zipfel et al, 2004, 2006). Notably,
this PAMP-induced accumulation is attenuated by T3SEs (Figure 7A;
compare hrcC− with WT). However, this T3SE-mediated suppression was
much less marked after inoculation with Pto DC3000 ΔhopU1 (Figure 7A;
compare ΔhopU1 with WT). Importantly, expression of HopU1 in trans on a
plasmid in Pto DC3000 ΔhopU1 restored the inhibition of FLS2
accumulation during infection, while trans-complementation with the
catalytically inactive HopU1DD variant (Fu et al, 2007; Jeong et al, 2011)
did not (Figure 7B). In addition, HopU1 does not affect BAK1 levels during
infection (Supplementary Figure S10); consistent with our previous finding
that GRP7 does not bind BAK1 mRNA (Figures 5 and 6; Supplementary
Figure S8).
Notably, while the amount of cellular FLS2 mRNA increased during the
first hours of infection with Pto DC3000 hrcC−, it decreased to a similar
level upon infection with Pto DC3000 WT and ΔhopU1 (Figure 7C). The
contrasting regulation and sensitivity to HopU1 of FLS2 mRNA and protein
levels during infection further demonstrate that HopU1 regulates FLS2 posttranscriptionally, while other T3SEs already regulate FLS2 at the
12

transcriptional level. Consistent with FLS2 being an important virulence
target for HopU1, we found that deletion of the flagellin-encoding gene fliC
in the ΔhopU1 background (Pto DC3000 ΔhopU1 ΔfliC) suppresses the
virulence defect of Pto DC3000 ΔhopU1 and restores the virulence of Pto
DC3000 ΔhopU1 ΔfliC to a comparable level as Pto DC3000 ΔfliC on WT
A. thaliana plants (Figure 7D). Together, these results indicate that HopU1
strongly affects the increased accumulation of FLS2 protein level normally
observed during the first hours of A. thaliana infection by Pto DC3000.

Discussion
Several animal and plant pathogenic bacteria use toxins or T3SEs that
possess mono-ADP-RT activity as major virulence factors via the targeting
of distinct host proteins (Deng and Barbieri, 2008; Block and Alfano, 2011).
The mono-ADP-RT toxins diphtheria toxin (DT) from Corynebacterium
diphtheriae, ExoA from P. aeruginosa and cholix toxin (CT) from Vibrio
cholerae interact with the eukaryotic elongation factor eEF2 as a unique
specific host target (Deng and Barbieri, 2008; Jorgensen et al, 2008). In
contrast, other mono-ADP-RTs (e.g., the T3SE ExoS from P. aeruginosa)
target numerous host proteins (Hauser, 2009). The study of mono-ADP-RT
T3SEs from phytopathogenic bacteria is still in its infancy. HopU1 from Pto
DC3000 was the first from this family with a proven role in virulence and
targets several plant RBPs, including GRP7 and GRP8 (Fu et al, 2007).
More recently, the plasma membrane-targeted T3SE mono-ADP-RT HopF2
from Pto DC3000 was also shown to target multiple plant proteins,
including the MAP kinase kinase MKK5 and the important immune
regulator RIN4, to suppress PTI and cause disease (Wang et al, 2010;
Wilton et al, 2010; Wu et al, 2011). The T3SE HopF1/AvrPphF from P.
syringae pv. phaseolicola race 7 shows weak homology to mono-ADP-RTs
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and is required for virulence on bean (Tsiamis et al, 2000; Singer et al,
2004), but no corresponding host target has been identified so far.
GRP7 is required for PTI responses triggered by several PAMPs, including
flg22, elf18 and chitin (Fu et al, 2007; Jeong et al, 2011). In addition, we
have shown that GRP7 overexpression increases early and late PTI
responses triggered by these PAMPs (Figure 1). Similarly, loss of and
overexpression of GRP7 leads to reduced and increased resistance to Pto
DC3000, respectively (Figure 1; Fu et al, 2007; Jeong et al, 2011). These
results demonstrate that GRP7 is an important immune regulator that is both
required and limiting for full immunity to Pto DC3000. Despite these
findings, the exact role of GRP7 in PTI was still unclear. RBPs can be
involved in different aspects of RNA metabolism (e.g., splicing, transport,
storage, translation and degradation) (Keene, 2007). According to a
potential role in RNA-related processes, we found that GRP7 associates in
vivo specifically with several components of the translational machinery,
including elF4A1, elF4A2, eEF1A, elF4E and S14 (Figures 3 and 4;
Supplementary Figure S7; Supplementary Table S1). The association of
GRP7 with an active translational complex is further suggested by the
enrichment of a slower migrating form of eIF4E in the GRP7
immunoprecipitate (Figures 3 and 4; Supplementary Figure S7), which may
correspond to the phosphorylated active form of eIF4E that is linked to the
mRNA cap (Beretta et al, 1998; Raught and Gingras, 1999; Dyer et al,
2003).
Unexpectedly, we also found that GRP7 directly interacts in vivo with the
PRRs FLS2 and EFR in a specific manner (Figure 2; Supplementary Figure
S3), as GRP7 did not interact with the LRR-RLK BAK1 (Figure 2C) that is
involved in PTI signalling downstream of FLS2 and EFR (Chinchilla et al,
14

2007; Heese et al, 2007; Roux et al, 2011). Notably, the interaction between
GRP7 and FLS2 (and EFR) appears to be at the plasma membrane, as
indicated by the localization of the YFP signal in BiFC experiments (Figure
2E; Supplementary Figure S3B) and the presence of FLS2 (and EFR) in coimmunoprecipitation experiments (Figures 2A, B and D). In addition, GRP7
and GRP8 are present in highly purified A. thaliana plasma membrane
preparations (Alexandersson et al, 2004). Interestingly, a potential direct
and dynamic link between the GRP7–FLS2 complex and the complex
between GRP7 and translational components is indicated by the flg22induced dissociation of elF4E and S14 from the GRP7 complex (Figure 3).
This observation is reminiscent of the recent demonstration in mammals
and plants of transmembrane receptor-associated translational regulation
complexes that most likely enable rapid activation of ligand-induced
translation (Ehsan et al, 2005; Carvalho et al, 2008; Lin et al, 2010;
Tcherkezian et al, 2010). Previous electron microscopy experiments
revealed the presence of polysomes anchored to the plasma membrane via
actin filaments in both plant and animal cells (Hovland et al, 1996; Medalia
et al, 2002). Therefore, the reported association of FLS2 with translation
regulation complexes at the plasma membrane is of great interest for further
studies.
However, we found that HopU1 does not directly target FLS2 by monoADP-ribosylation (Supplementary Figure S5), nor perturb the association or
the dissociation between GRP7 and FLS2 or translational components
(Figure 4; Supplementary Figure S7) despite directly interacting with GRP7
(Supplementary Figure S6). These results suggest that HopU1 targets
another molecular function of GRP7 that is independent of the
aforementioned protein–protein interactions. In addition to the previously
reported binding of GRP7 to its own transcript and that of GRP8 in vitro
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(Staiger et al, 2003; Schoning et al, 2008), we found that GRP7 binds the
transcripts of FLS2 and EFR in vivo, but not of BAK1 (Figure 5A;
Supplementary Figure S8). As shown for its own transcript (Schoning et al,
2007), GRP7 binds the 3′-UTR of FLS2 mRNA in vitro (Figures 5B and C).
To our knowledge, FLS2 and EFR correspond to the first described non-RBP
cargo mRNAs bound by GRP7 and GRP8 with a clear biological function.
However, it is clear that GRP7 carries other cargo mRNAs involved in
immunity and other processes that require identification, as GRP7 has been
also involved in circadian clock, flowering time and tolerance to abiotic
stresses (Mangeon et al, 2010). An effect on these cargo mRNAs may
explain some of the immune phenotypes observed in the GRP7
overexpressing lines. Importantly, however, we demonstrated that HopU1
inhibits the GRP7–FLS2 mRNA and GRP7–EFR mRNA interactions in vivo,
and that these interactions depend on R49 (Figure 6; Supplementary Figure
S8), the conserved residue that is mono-ADP-ribosylated by HopU1 and
located within the RRM RNA-binding domain of GRP7 (Jeong et al, 2011).
This is consistent with the previously reported importance of this residue for
RNA binding in vitro (Schoning et al, 2007; Jeong et al, 2011). Our results
provide examples of relevant immune-related target mRNAs whose binding
to GRP7 is inhibited by HopU1 in vivo. Furthermore, we could show that the
injection of HopU1 by the type III secretion system during Pto DC3000
infection leads to reduced FLS2 accumulation in planta (Figure 7). Notably,
the effect of HopU1 on FLS2 amounts is comparable to the previously
described effect of the Pto DC3000 T3SE AvrPtoB or the Arabidopsis E3
ligases PUB12/13 (Gohre et al, 2008; Lu et al, 2011). This suggests that the
inability of GRP7 to bind FLS2 mRNA ultimately results in decreased FLS2
accumulation during infection, potentially by inhibiting FLS2 translation.
In apparent contradiction to our model, we only found slightly reduced
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FLS2 protein levels in HopU1 A. thaliana seedlings under sterile conditions
(Supplementary Figure S2C). However, we hypothesize that GRP7 is not
involved in steady-state synthesis of FLS2, but rather regulates pathogeninduced FLS2 translation. Indeed, FLS2 gene expression is induced upon
PAMP treatment (Zipfel et al, 2004, 2006), and FLS2 accumulates strongly
upon infection with Pto DC3000 hrcC− (Figure 7A) that only triggers PTI,
given its inability to secrete PTI-suppressing T3SEs. Notably, consistent
with the fact that GRP7 does not bind BAK1 mRNA (Figures 5 and 6;
Supplementary Figure S8), HopU1 does not affect BAK1 protein levels
during infection (Supplementary Figure S10).
In accordance with our hypothesis, we observed that GRP7ox seedlings
accumulate about 20% more FLS2 protein after 4 h of flg22 treatment than
WT seedlings (Supplementary Figure S11). Although we could not prove
that FLS2 mRNA was associated with GRP7 in complex with FLS2 at the
plasma membrane, our results suggest the existence of a complex including
FLS2 mRNA, GRP7, translational components and FLS2 in a plasma
membrane-associated complex that may contribute to pathogen-induced de
novo translation of FLS2 during the early steps of plant infection. An
additional argument in favour of this hypothesis is that flg22 perception
induces the release of the 43S complex from GRP7, potentially to start de
novo protein synthesis. Notably, flg22 binding leads to FLS2 endocytosis
and FLS2 degradation upon binding to E3 ligases (Robatzek et al, 2006; Lu
et al, 2011). Therefore, it is possible that de novo pathogen-induced FLS2
translation is involved in the rapid replenishment of the plasma-membrane
pool of ligand-free FLS2. In this model, HopU1 would inhibit GRP7–FLS2
mRNA interaction and thus block the recruitment of FLS2 transcripts into
the plasma membrane-associated complex, leading most likely to the
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inhibition of de novo pathogen-induced FLS2 translation. Further work will
be needed to test this model.
During the infection process, pathogenic effectors must collaborate in a
complementary manner to suppress efficiently host innate immune
responses. Importantly, the secretion and action of T3SEs occur after or
while PAMPs are perceived, given that the T3SS is only induced in planta
(Boch et al, 2002). The T3SEs AvrPto and AvrPtoB target the FLS2 pathway
by blocking the activation of FLS2 and/or BAK1, and by inducing FLS2
degradation (Xing et al, 2007; Gohre et al, 2008; Shan et al, 2008; Xiang et
al, 2008, 2011; Gimenez-Ibanez et al, 2009; Cheng et al, 2011; Zeng et al,
2012). In addition, the T3SEs AvrPphB and AvrAC target the immediate
substrate of the FLS2-BAK1 complex, BIK1 and related proteins, for
degradation or inhibition, respectively (Zhang et al, 2010; Feng et al, 2012).
In this paper, we reveal that HopU1 may have a synergic effect with
previously described Pseudomonas T3SEs by inhibiting PAMP-induced de
novo FLS2 synthesis, which would otherwise compensate for the negative
action of AvrPto, AvrPtoB and AvrPphB on innate immunity. The
importance of FLS2 as an important virulence target for HopU1 is
demonstrated by the strict dependency on the presence of flagellin to
observe the hypo-virulence phenotype of Pto DC3000 ΔhopU1 on WT A.
thaliana plants (Figure 7D).
The demonstration that GRP7 binds PRR-encoding transcripts, and that the
Pto DC3000 T3SE HopU1 inhibits this interaction in a manner dependent on
its mono-ADP-RT activity ultimately leading to reduced PRR accumulation
during infection, provides a first direct link between GRP7 and a function in
PTI, and reveals a novel virulence mechanism employed by bacterial
pathogens. This mechanism is in contrast with the virulence strategy
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employed by C. diphtheriae, P. aeruginosa and V. cholerae that use their
mono-ADP-RT toxins (DT, ExoA and colix toxin, respectively) to eradicate
host translation via the targeting of eEF2 (Deng and Barbieri, 2008;
Jorgensen et al, 2008). In addition, the virulence strategy used by HopU1
differs from strategies deployed by previously described T3SEs from
phytopathogenic bacteria that target the PRR proteins themselves or the
signalling triggered by PRR activation (Block and Alfano, 2011).

Materials and methods
Plant material
A. thaliana, N. benthamiana and N. tabacum were grown at 20–21°C with a
10-h-photoperiod in environmentally controlled chambers. Arabidopsis
seedlings were grown on plates containing Murashige and Skoog (MS)
medium (Duchefa) and 1% sucrose at 22°C with a 16-h photoperiod.
All experiments were performed in Col-0 background, except if indicated
otherwise. The fls2 mutant used in this study is SALK_093905. The GRP7ox
(Col-2/35S::GRP7), HopU1 (Col-0/35S::HopU1-HA), GRP7-GFP (Col0/35S::GRP7-GFP), GRP7-HA (grp7-1/GRP7p::GRP7-HA) and
GRP7(R49K)-HA [grp7-1/GRP7p::GRP7(R49K)-HA] were previously
published in Fu et al (2007); Kim et al (2008); Streitner et al (2008); Jeong
et al (2011). The GRP7-GFP/HopU1 line was obtained by crossing the
GRP7-GFP and HopU1 lines.
The estradiol-inducible HopU1 line (ind_HopU1) was obtained by
transforming Col-0 with the vector pLN604 (derived from pER8; Zuo et al,
2000) carrying hopU1-HA. The expression of HopU1 was induced by
spraying 15 μM β-estradiol for 16–20 h. The GRP8-HA (Col-0/35S::GRP819

HA) line was obtained by transforming Col-0 with the binary vector
pPZP212 carrying GRP8-HA. Homozygous lines with a single transgene
insertion were used for the experiments.

PTI assays
PAMP treatments (flg22 and elf18 peptides synthetized by Peptron, South
Korea; shrimp chitin from SIGMA) were performed by syringe infiltration
of plant leaves or by addition of the elicitor into the liquid media. Oxidative
burst assays were performed on leaf disks incubated in a solution containing
luminol and peroxidase as previously described (Zipfel et al, 2004). Callose
deposition was observed after infiltration with a solution of 1 μM PAMP for
16 h as previously described (Hann and Rathjen, 2007). Callose deposits
were quantified using PDQuest software (Bio-Rad).

Pseudomonas infection
Bacterial strains used in this study were Pseudomonas syringae pv. tomato
(Pto) DC3000 WT, Pto DC3000 ΔhopU1 and Pto DC3000 hrcC−. For
bacterial enumeration assays, plants were sprayed with the strains WT
(inoculum: 106 cfu/ml), ΔhopU1 (inoculum: 108 cfu/ml) and hrcC−
(inoculum: 108 cfu/ml), in the presence of 0.001% (v/v) Silwet L-77.
Sprayed plants were then covered with a transparent plastic lid for the
remaining of the experiment. For the other assays, bacteria were infiltrated
into Arabidopsis leaves with the strains WT (inoculum: 5 × 107 cfu/ml),
ΔhopU1 (inoculum: 108 cfu/ml) and hrcC− (inoculum: 108 cfu/ml).
For the trans-complementation experiment described in Figure 7, pLN1981,
encoding HopU1-HA, and pLN1982, encoding HopU1DD-HA, were
electroporated into UNL141, the DC3000 ΔhopU1 mutant (Fu et al, 2007).
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The ΔhopU1(HopU1) and ΔhopU1(HopU1DD) strains were confirmed to
produce HopU1-HA and HopU1DD-HA prior to using these strains to infect
Arabidopsis.
The construction of ΔfliC mutant was done by unmarked mutagenesis
(House et al, 2004). A 1.9-kb upstream (US) DNA sequence and 1.5-kb
downstream (DS) were amplified by PCR using the primers fliC us-F
(CACCGAGGTTACATGCAACGCCTG) and fliC us-R
(CATGATGAATTCCTCGTTGG) and fliC ds-F
(CACCCAGTAATATCGGCATGAG) and fliC-R
(CGCTGATCGAACCCTTGGTC). The purified PCR products were cloned
into the pENTR/D-TOPO vector (Invitrogen). Entry constructs were then
recombined by LR reactions into pMK2017 for US sequence and pMK2016
for DS sequences. These plasmids were separately introduced into DC3000
and plated onto media selecting for integration of each plasmid into DC3000
genome. Deletion of fliC was performed following a previously published
protocol (Crabill et al, 2010). For construction of the fliC hopU1 double
mutant, ΔfliC was used as a background strain to generate a hopU1 deletion
mutation via homologous recombination using constructs described in Fu et
al (2007). The resulting mutants were confirmed with PCR using primers
that annealed to the flanking regions of either fliC or hopU1.

Yeast two-hybrid
The coding region corresponding to the cytoplasmic part of EFR (EFRcyt)
was cloned in the pLexA vector. The recombinant pLexA-EFRcyt was used
to screen a cDNA library prepared from infected Arabidopsis plants (van der
Biezen et al, 2000) according to the indications of the manufacturer (LexA
system-based yeast two hybrid; CLONTECH). The coding region of GRP7
from the nucleotides 67 to 528 (corresponding to the region of the GRP7
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clone identified during the initial screen) was re-cloned in the pB42AD
vector to retest the interaction.

Agrobacterium-mediated transient expression for coimmunoprecipitation, subcellular localization and BiFC experiments
For the co-immunoprecipitation and subcellular localization experiments,
we used the following previously described constructs: 35S::GRP7-eGFP
(Fu et al, 2007), 35S::EFR-3 × HA (Schwessinger et al, 2011), 35S::FLS2-3
× myc (Chinchilla et al, 2006), 35S::BAK1-HA (Schwessinger et al, 2011),
35S::FLS2-GFP-His (Schwessinger et al, 2011) and 35S::HopU1-HA (Fu et
al, 2007). The Agrobacterium strains GV3101 carrying the indicated
constructs were syringe-infiltrated in N. benthamiana or N. tabacum leaves
at OD600=0.4–0.6 and samples were collected 2 days post infiltration.
For the BiFC assays, we cloned the coding regions of FLS2, EFR, GRP7 and
HopU1 into the BiFC binary vectors pAM-PAT-35S that were previously
described in Lefebvre et al (2010). The Agrobacterium strain GV3101
expressing the silencing suppressor P19 (Voinnet et al, 2003) and carrying
the indicated constructs were syringe-infiltrated in N. benthamiana leaves at
OD600=0.4–0.6.
Confocal analyses for the subcellular localization and BiFC experiments
were performed 2 days post infiltration using a Leica SP5 confocal
microscope.

Protein extraction, co-immunoprecipitation and immunoblotting
Total proteins were extracted in a buffer including 100 mM Tris–HCl pH
7.5, 150 mM NaCl, 5 mM EDTA, 5% glycerol, 10 mM DTT, 0.5% Triton X100, 1% Igepal and protease inhibitors (Sigma). For co22

immunoprecipitation, anti-HA beads (Roche) or anti-GFP-TRAP-A beads
(Chromotek) were incubated with total proteins and then washed with the
extraction buffer. Proteins were fractioned on SDS–PAGE, transferred onto
PVDF membranes (Bio-Rad) and then detected using specific antibodies.
FLS2 was detected using specific polyclonal antibodies raised in rabbit as
primary antisera. The anti-S14-1 antibodies were purchased (Agrisera,
Sweden). The rabbit anti-eIF4E antibody was a kind gift from Professor A
Maule (John Innes Centre, Norwich, UK). Epitope-tagged proteins were
detected with a peroxidase-conjugated anti-HA-HRP (Santa Cruz); mouse
monoclonal anti-GFP antibodies (AMS); or anti-HRP antibodies (Santa
Cruz). The secondary anti-rabbit-HRP antibodies (Sigma) were used when
appropriate. Immunodetection was performed with ECL chemiluminescence
reagent (GE). Tandem mass-spectrometry experiments have been performed
as previously described (Fu et al, 2007).

In vitro ADP-ribosylation assay
HopU1-His, GRP7-GST and FLS2-GST were affinity-purified from
Escherichia coli BL21 and the purity of the proteins was examined by SDS–
PAGE. The ADP-ribosylation assay was performed as previously (Fu et al,
2007).

RNA-immunoprecipitation assay
After UV-crosslinking treatments (120 MJ, 3 times using UV StratalinkerTM
2400, Stratagene), total proteins were extracted in extraction buffer
including 50 mM Tris–HCl pH 8, 150 mM NaCl, 2.5 mM EDTA, 10%
glycerol, 10 mM PMSF, 10 units/ml RNaseOUT (Invitrogen) and protease
inhibitors (Sigma). After centrifugation, the supernatant was incubated with
anti-HA affinity matrix (Roche) or anti-GFP-TRAP-A beads (Chromotek).
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After this incubation, the beads were washed and the RNA-GRP7 complexes
were eluted by incubating at 60°C for 15 min in the elution buffer (1% SDS,
0.1 M NaHCO3). A proteinase K treatment for 1 h at 60°C was then followed
by RNA extraction and quantitative RT–PCR.
In each experiment, transcript levels from the input have been normalized in
comparison to the control samples (grp7/GRP7-HA in Figures 5A and 6B
and Supplementary Figure S7B; HopU1 in Figure 6A and Supplementary
Figure S7A; and Col-0 in Supplementary Figure S8). The normalization of
the transcript levels after RNA-IP has been performed in comparison to the
GRP7 transcript level in grp7/GRP7-HA or GRP7-GFP samples (Figures 5A,
6A and B, Supplementary Figures S7A and B) or the GRP8 transcript level
(Supplementary Figure S8).

Quantitative RT–PCR
After RNA extraction (Tri Reagent, Sigma-Aldrich), first-strand cDNA was
synthesized using the SuperScript II Reverse Transcriptase (Invitrogen).
Quantitative PCRs were performed from 1.5 μl of cDNA with SYBR Green
JumpStart Taq ReadyMix (Sigma-Aldrich) on a PTC-200 Peltier Thermal
Cycler (MJ Research, Waltham, MA). Primers used are
Ubox (At5g15400): 5′-TGCGCTGCCAGATAATACACTATT-3′ and
5′-TGCTGCCCAACATCAGGTT-3′
FLS2 (At5g46330): 5′-ACTCTCCTCCAGGGGCTAAGGAT-3′ and
5′-AGCTAACAGCTCTCCAGGGATGG-3′
EFR (At5g20480): 5′-CGGATGAAGCAGTACGAGAA-3′ and
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5′-CCATTCCTGAGGAGAACTTTG-3′
BAK1 (At4g33430): 5′-ACCGCCTCCTATCTCTCCTACACC-3′ and
5′-CTGGGTCCTCTTCAGCTGGTACA-3′
GRP7 (At2g21660): 5′-TGATGACAGAGCTCTTGAGACTGCC-3′ and
5′-TCCTCCTCCACCCTCGCGTCTACCGCCGCCA-3′
GRP8 (At4g39260): 5′-CAATGATGAAGATCTTCAAAGGACG-3′ and
5′-CTCGTAACCACCACCGCCTCCTCCTGAGTATCC-3′

Electrophoretic mobility shift assay
The 3'-UTR sequence of FLS2 was amplified with the upstream primer
GATGGTACCGAAGTTTAGCAGCAAAGC and the downstream primer
GAGCTCGAGGTTCATCAAAACCAAATTTC. The amplified fragment
was subcloned into the plasmid pBSK(-) (Stratagene) and transcribed with
T7 polymerase (Promega) in the presence of 10 μCi 32P CTP. The FLS2 3′UTR binding affinity was analysed with purified GRP7-GST in 20 mM
HEPES, pH 7.5, 100 mM NaCl, 1 mM MgCl2, 0.01% NP-40, 10 U
SUPERase·In (Ambion), and 50 ng of 32P-labelled FLS2 3′-UTR. Inhibition
of RNA binding ability by HopU1 was tested by first producing mono-ADPribosylated GRP7, then performing an electrophoretic mobility shift assay.
Four μM GRP7-GST was incubated with 1 μM HopU1-His or HopU1DD-His
in the standard ADP-ribosylation reaction followed by analysis of RNA
binding ability. For competition assays, unlabelled FLS2 3'-UTR transcripts
were added into the mixture of 2 μM GRP7-GST and 50 ng of 32P-labelled
FLS2 3′-UTR transcripts. The bound and free RNA probes were separated
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on 6% native PAGE and exposed to PhotoImage screen, then analysed by
Storm 860 scanner (Molecular Dynamics).

Statistical analysis
Statistical significances based on one-way ANOVA were performed with
Prism 5.01 software (GraphPad Software).
View larger version

Figure 1. GRP7 overexpression enhances significantly PTI
responses and resistance to Pseudomonas infection. (A) Oxidative
burst triggered by 1 μM flg22, 1 μM elf18, 100 μg/ml chitin or in
absence of PAMP treatment in Col-2 and transgenic A. thaliana
plants overexpressing GRP7 (GRP7ox). ROS production is presented as total photon
count during 25 min of treatment and measured in relative light units (RLUs). Values
are mean±s.e. (n=6). Statistical significance was assessed using the ANOVA test
(P<0.001). (B) Callose deposition induced by 1 μM flg22, 1 μM elf18, 100 μg/ml chitin
or in absence of PAMP treatment, directly infiltrated in Col-2 and transgenic A.
thaliana plants overexpressing GRP7 (GRP7ox). Values are mean±s.e. (n=24).
Statistical significance was assessed using the ANOVA test (P<0.001). ND, nondetectable. (C) Growth of Pseudomonas syringae pv. tomato (Pto) DC3000 on Col-2
and GRP7ox plants as measured by colony forming units (cfu). Bacterial growth was
measured 4 days after spray inoculation with the wild-type strain (WT) or the hrcC−
strain. Values are mean±s.e. (n=4). dai, days after inoculation. Statistical significance
was assessed using the ANOVA test (P<0.001; letters indicate statistically significant
differences). (D) Disease symptoms on Col-2 and GRP7ox plants, 4 days after spray
infection with Pto DC3000 WT. All results shown are representative of at least three
independent experiments.
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View larger version

Figure 2. GRP7 associates with FLS2 at the plasma membrane.
(A–C) Co-immunoprecipitation assay performed after transient coexpression of GRP7-eGFP or eGFP with EFR-3 × HA (A), FLS2-3 ×
myc (B) or BAK1-HA (C) in N. benthamiana plants. Total proteins
(input) were subjected to immunoprecipitation with GFP Trap beads
followed by immunoblot analysis. (D) Co-immunoprecipitation of GRP7 and FLS2 in
A. thaliana. Co-immunoprecipitation assay performed on Col-0 and GRP7-GFP
plants untreated (−) or treated (+) with 1 μM flg22 for 15 min. Total proteins (input) were
subjected to immunoprecipitation with GFP Trap beads followed by immunoblot
analysis. (E) Bimolecular fluorescence complementation assays between GRP7 and
FLS2. YFPn, GRP7-YFPn, YFPc and FLS2-YFPc, as well as the reverse
combinations YFPc, GRP7-YFPc, YFPn and FLS2-YFPn, were transiently coexpressed in N. benthamiana leaves. Plasmolysis experiment was performed in the
presence of 5% NaCl for 5 min. Arrows indicate Hechtian strands. The chlorophyll
autofluorescence appears in red. Scale bar corresponds to 20 μm. Photographs were
taken 2 days after infiltration and are representative of the total observations (n=60).
All results shown are representative of three independent experiments.

View larger version

Figure 3. GRP7 associates with translational components in
Arabidopsis. Co-immunoprecipitation of GRP7 and translational
components in A. thaliana. Co-immunoprecipitation assay
performed on Col-0 and GRP7-GFP plants untreated (−) or treated (+) with 1 μM flg22
for 15 min. Total proteins (input) were subjected to immunoprecipitation with GFP Trap
beads followed by immunoblot analysis with anti-GFP antibodies to detect GRP7GFP or specific antibodies recognizing the translation initiation factor elF4E and the
ribosomal protein S14. Asterisks mark eIF4E slower migrating bands. The results
shown are representative of three independent experiments.
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View larger version

Figure 4. HopU1 does not affect the protein–protein
interactions between GRP7, FLS2 and translational components.
Co-immunoprecipitation of GRP7-associated proteins in the
presence of HopU1 in A. thaliana. Co-immunoprecipitation assay performed on Col-0
and HopU1 plants expressing or not GRP7-GFP. Total proteins (input) were subjected
to immunoprecipitation with GFP Trap beads followed by immunoblot analysis with
anti-GFP antibodies to detect GRP7 or specific antibodies recognizing FLS2, the
translation initiation factor elF4E, or the ribosomal protein S14. Asterisks mark slower
migrating band forms. The results shown are representative of three independent
experiments.

View larger version

Figure 5. GRP7 binds FLS2 transcript. (A) RNA
immunoprecipitation in grp7-1 and grp7-1/GRP7-HA A. thaliana
lines treated for 30 min with water or 1 μM flg22. Total proteins were
subjected to immunoprecipitation with anti-HA antibodies followed by
quantitative RT–PCR analysis of FLS2, BAK1, GRP7 and GRP8 transcripts with
specific primers. Values are mean±s.e. (n=4). The results shown are representative of
three independent experiments. (B, C) GRP7 binds the 3′UTR of FLS2 transcripts in
vitro. Electrophoretic shift assays performed on the 3′UTR of FLS2 RNAs, in presence
of increasing concentrations of GRP7-GST (B). Competition assay was performed
with increasing quantity of unlabelled FLS2 3′UTR transcripts to GRP7-GST and 32Plabelled FLS2 3'UTR transcripts (C). The results shown are representative of three
independent experiments.
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View larger version

Figure 6. HopU1 disrupts GRP7–FLS2 transcripts interactions.
(A) RNA immunoprecipitation in HopU1, GRP7-GFP and GRP7GFP/HopU1 A. thaliana lines. Total proteins were subjected to
immunoprecipitation with GFP Trap beads followed by quantitative
RT–PCR analysis of BAK1, FLS2 and GRP7 transcripts with
specific primers. Values are mean±s.e. (n=4). (B) RNA immunoprecipitation in grp7,
grp7/GRP7-HA and grp7/GRP7(R49K)-HA A. thaliana lines. Total proteins were
subjected to immunoprecipitation with anti-HA matrix beads followed by quantitative
RT–PCR analysis of BAK1, FLS2, GRP7 and GRP8 transcripts with specific primers.
Values are mean±s.e. (n=4). (C) Electrophoretic shift assays in the presence of
HopU1 and its inactive version HopU1DD. Standard ADP-ribosylation reaction was
performed with 4 μM GRP7-GST in the presence of 1 μM HopU1 or HopU1DD. The
corresponding GRP7-GST was then added to the 3′-UTR of FLS2 transcript binding
assay. The results shown are representative of three independent experiments.

29

View larger version

Figure 7. HopU1 inhibits FLS2 protein accumulation during
infection. (A) Immunoblots with specific antibodies detecting
endogenous FLS2 in Col-0 during bacterial infection after syringe
inoculation with Pto DC3000 (WT; inoculum: 5 × 107 cfu/ml), Pto DC3000 ΔhopU1
(inoculum: 108 cfu/ml), Pto DC3000 hrcC− (inoculum: 108 cfu/ml). hpi, hours post
infection; CBB, Coomassie Brilliant Blue. Values correspond to signal intensity of the
FLS2-specific band from the immunoblots relative to the zero time point. (B)
Immunoblots with specific antibodies detecting endogenous FLS2 in Col-0 during
bacterial infection after syringe inoculation with Pto DC3000 (WT; inoculum: 5 × 107
cfu/ml), Pto DC3000 ΔhopU1 (inoculum: 108 cfu/ml), Pto DC3000 ΔhopU1 [HopU1]
(inoculum: 108 cfu/ml), Pto DC3000 ΔhopU1 [HopU1DD] (inoculum: 108 cfu/ml). hpi,
hours post infection; CBB, Coomassie Brilliant Blue. Values correspond to signal
intensity of the FLS2-specific band from the immunoblots relative to the zero time
point. (C) FLS2 transcript level as measured by quantitative RT–PCR in Col-0 plants
during bacterial infection after syringe inoculation with Pto DC3000 (WT; inoculum: 5 ×
107 cfu/ml), Pto DC3000 ΔhopU1 (inoculum: 108 cfu/ml), Pto DC3000 hrcC−
(inoculum: 108 cfu/ml). hpi, hours post infection. (D) Bacterial growth measured during
Pseudomonas infection in Col-0 plants, after spray inoculation (inoculum: 2 × 108
cfu/ml) with Pto DC3000 wild-type (WT) or the derivated strains ΔfliC, ΔhopU1 and
ΔhopU1ΔfliC. Growth measured by colony forming units (cfu) 4 days after inoculation.
Values are mean±s.e. (n=4). Statistical significance was assessed using the ANOVA
test (P<0.001; letters indicate statistically significant differences). dai, days after
inoculation. The results shown are representative of three independent experiments.
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Figure 1.
GRP7 overexpression enhances significantly PTI responses and resistance to
Pseudomonas infection. (A) Oxidative burst triggered by 1 μM flg22, 1 μM elf18,
100 μg/ml chitin or in absence of PAMP treatment in Col-2 and transgenic A.
thaliana plants overexpressing GRP7 (GRP7ox). ROS production is presented as
total photon count during 25 min of treatment and measured in relative light units
(RLUs). Values are mean±s.e. (n=6). Statistical significance was assessed using the
ANOVA test (P<0.001). (B) Callose deposition induced by 1 μM flg22, 1 μM elf18,
100 μg/ml chitin or in absence of PAMP treatment, directly infiltrated in Col-2 and
transgenic A. thaliana plants overexpressing GRP7 (GRP7ox). Values are mean
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±s.e. (n=24). Statistical significance was assessed using the ANOVA test (P<0.001).
ND, non-detectable. (C) Growth of Pseudomonas syringae pv. tomato (Pto)
DC3000 on Col-2 and GRP7ox plants as measured by colony forming units (cfu).
Bacterial growth was measured 4 days after spray inoculation with the wild-type
strain (WT) or the hrcC− strain. Values are mean±s.e. (n=4). dai, days after
inoculation. Statistical significance was assessed using the ANOVA test (P<0.001;
letters indicate statistically significant differences). (D) Disease symptoms on Col-2
and GRP7ox plants, 4 days after spray infection with Pto DC3000 WT. All results
shown are representative of at least three independent experiments.
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Figure 2.
GRP7 associates with FLS2 at the plasma membrane. (A–C) Coimmunoprecipitation assay performed after transient co-expression of GRP7-eGFP
or eGFP with EFR-3 × HA (A), FLS2-3 × myc (B) or BAK1-HA (C) in N.
benthamiana plants. Total proteins (input) were subjected to immunoprecipitation

41

with GFP Trap beads followed by immunoblot analysis. (D) Co-immunoprecipitation
of GRP7 and FLS2 in A. thaliana. Co-immunoprecipitation assay performed on Col0 and GRP7-GFP plants untreated (−) or treated (+) with 1 μM flg22 for 15 min. Total
proteins (input) were subjected to immunoprecipitation with GFP Trap beads
followed by immunoblot analysis. (E) Bimolecular fluorescence complementation
assays between GRP7 and FLS2. YFPn, GRP7-YFPn, YFPc and FLS2-YFPc, as
well as the reverse combinations YFPc, GRP7-YFPc, YFPn and FLS2-YFPn, were
transiently co-expressed in N. benthamiana leaves. Plasmolysis experiment was
performed in the presence of 5% NaCl for 5 min. Arrows indicate Hechtian strands.
The chlorophyll autofluorescence appears in red. Scale bar corresponds to 20 μm.
Photographs were taken 2 days after infiltration and are representative of the total
observations (n=60). All results shown are representative of three independent
experiments.
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Figure 3.
GRP7 associates with translational components in Arabidopsis. Coimmunoprecipitation of GRP7 and translational components in A. thaliana. Coimmunoprecipitation assay performed on Col-0 and GRP7-GFP plants untreated (−)
or treated (+) with 1 μM flg22 for 15 min. Total proteins (input) were subjected to
immunoprecipitation with GFP Trap beads followed by immunoblot analysis with antiGFP antibodies to detect GRP7-GFP or specific antibodies recognizing the
translation initiation factor elF4E and the ribosomal protein S14. Asterisks mark
eIF4E slower migrating bands. The results shown are representative of three
independent experiments.
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Figure 4.
HopU1 does not affect the protein–protein interactions between GRP7, FLS2 and
translational components. Co-immunoprecipitation of GRP7-associated proteins in
the presence of HopU1 in A. thaliana. Co-immunoprecipitation assay performed on
Col-0 and HopU1 plants expressing or not GRP7-GFP. Total proteins (input) were
subjected to immunoprecipitation with GFP Trap beads followed by immunoblot
analysis with anti-GFP antibodies to detect GRP7 or specific antibodies recognizing
FLS2, the translation initiation factor elF4E, or the ribosomal protein S14. Asterisks
mark slower migrating band forms. The results shown are representative of three
independent experiments.
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Figure 5.
GRP7 binds FLS2 transcript. (A) RNA immunoprecipitation in grp7-1 and grp71/GRP7-HA A. thaliana lines treated for 30 min with water or 1 μM flg22. Total
proteins were subjected to immunoprecipitation with anti-HA antibodies followed by
quantitative RT–PCR analysis of FLS2, BAK1, GRP7 and GRP8 transcripts with
specific primers. Values are mean±s.e. (n=4). The results shown are representative
of three independent experiments. (B, C) GRP7 binds the 3′UTR of FLS2 transcripts
in vitro. Electrophoretic shift assays performed on the 3′UTR of FLS2 RNAs, in
presence of increasing concentrations of GRP7-GST (B). Competition assay was
performed with increasing quantity of unlabelled FLS2 3′UTR transcripts to GRP7GST and 32P-labelled FLS2 3'UTR transcripts (C). The results shown are
representative of three independent experiments.
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Figure 6.
HopU1 disrupts GRP7–FLS2 transcripts interactions. (A) RNA immunoprecipitation
in HopU1, GRP7-GFP and GRP7-GFP/HopU1 A. thaliana lines. Total proteins were
subjected to immunoprecipitation with GFP Trap beads followed by quantitative RT–
PCR analysis of BAK1, FLS2 and GRP7 transcripts with specific primers. Values
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are mean±s.e. (n=4). (B) RNA immunoprecipitation in grp7, grp7/GRP7-HA and
grp7/GRP7(R49K)-HA A. thaliana lines. Total proteins were subjected to
immunoprecipitation with anti-HA matrix beads followed by quantitative RT–PCR
analysis of BAK1, FLS2, GRP7 and GRP8 transcripts with specific primers. Values
are mean±s.e. (n=4). (C) Electrophoretic shift assays in the presence of HopU1 and
its inactive version HopU1DD. Standard ADP-ribosylation reaction was performed
with 4 μM GRP7-GST in the presence of 1 μM HopU1 or HopU1DD. The
corresponding GRP7-GST was then added to the 3′-UTR of FLS2 transcript binding
assay. The results shown are representative of three independent experiments.
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Figure 7.
HopU1 inhibits FLS2 protein accumulation during infection. (A) Immunoblots with
specific antibodies detecting endogenous FLS2 in Col-0 during bacterial infection
after syringe inoculation with Pto DC3000 (WT; inoculum: 5 × 107 cfu/ml), Pto
DC3000 ΔhopU1 (inoculum: 108 cfu/ml), Pto DC3000 hrcC− (inoculum: 108 cfu/ml).
hpi, hours post infection; CBB, Coomassie Brilliant Blue. Values correspond to
signal intensity of the FLS2-specific band from the immunoblots relative to the zero
time point. (B) Immunoblots with specific antibodies detecting endogenous FLS2 in
Col-0 during bacterial infection after syringe inoculation with Pto DC3000 (WT;
inoculum: 5 × 107 cfu/ml), Pto DC3000 ΔhopU1 (inoculum: 108 cfu/ml), Pto DC3000
ΔhopU1 [HopU1] (inoculum: 108 cfu/ml), Pto DC3000 ΔhopU1 [HopU1DD]
(inoculum: 108 cfu/ml). hpi, hours post infection; CBB, Coomassie Brilliant Blue.
Values correspond to signal intensity of the FLS2-specific band from the
immunoblots relative to the zero time point. (C) FLS2 transcript level as measured by
quantitative RT–PCR in Col-0 plants during bacterial infection after syringe
inoculation with Pto DC3000 (WT; inoculum: 5 × 107 cfu/ml), Pto DC3000 ΔhopU1
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(inoculum: 108 cfu/ml), Pto DC3000 hrcC− (inoculum: 108 cfu/ml). hpi, hours post
infection. (D) Bacterial growth measured during Pseudomonas infection in Col-0
plants, after spray inoculation (inoculum: 2 × 108 cfu/ml) with Pto DC3000 wild-type
(WT) or the derivated strains ΔfliC, ΔhopU1 and ΔhopU1ΔfliC. Growth measured by
colony forming units (cfu) 4 days after inoculation. Values are mean±s.e. (n=4).
Statistical significance was assessed using the ANOVA test (P<0.001; letters
indicate statistically significant differences). dai, days after inoculation. The results
shown are representative of three independent experiments.
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Supplemental figures
Figure S1. GRP7 over-expression in the GRP7ox line.
Immunoblots with a specific antibody detecting GRP7 in Col-2 and the transgenic
Arabidopsis thaliana line overexpressing GRP7 (GRP7ox). The blot obtained with the
antibody anti-LHCP (Light Harvesting Chlorophyll a/b Protein) served as a loading
control.

Figure S2. HopU1 suppresses early and late immune responses triggered by
flg22 in Arabidopsis.
(A) Oxidative burst triggered by 50 nM flg22 or 50 nM elf18 in Col-0 and transgenic
Arabidopsis thaliana plants expressing HopU1-HA under 35S promoter (HopU1).
ROS production is presented as total photon count during 40 min of treatment and
measured in relative light units (RLU). Values are mean ± SE (n=12). Statistical
significance was assessed using the ANOVA test (P<0.001).
(B) Callose deposition induced by 1 μM flg22 infiltrated in Col-0 and transgenic
Arabidopsis thaliana plants expressing HopU1-HA under 35S promoter (HopU1).
Values are mean ± SE (n=10). Statistical significance was assessed using the
ANOVA test (P<0.001).
(C) Semi-quantitative immunoblot analysis with specific antibodies detecting
endogenous FLS2 in Col-0 and transgenic Arabidopsis thaliana plants expressing
HopU1-HA under 35S promoter (HopU1). Values correspond to signal intensity of the
bands from the immunoblots relative to the undiluted sample from Col-0. CBB,
Coomassie Brillant Blue. The results shown are representative of three out of four
independent experiments.
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(D) Oxidative burst triggered by 50 nM flg22 in Col-0 and transgenic Arabidopsis
thaliana plants expressing HopU1-HA under the control of an estradiol-inducible
promoter (ind_HopU1), with or without a 15 µM β-estradiol pre-treatment. ROS
production is presented as total photon count during 40 min of treatment and
measured in relative light units (RLU). Values are mean ± SE (n=12). Statistical
significance was assessed using the ANOVA test (P<0.001).
(E) Callose deposition induced by 1 μM flg22 infiltrated in Col-0 and transgenic
Arabidopsis thaliana plants expressing HopU1-HA under the control of an estradiolinducible promoter (ind_HopU1), with or without a 15 µM β-estradiol pre-treatment.
Values are mean ± SE (n=10). Statistical significance was assessed using the
ANOVA test (P<0.001).
(F) Growth of Pseudomonas syringae pv. tomato (Pto) DC3000 on Col-0, HopU1
(35S::HopU1-HA) and fls2 plants as measured by colony forming units (cfu).
Bacterial growth was measured three days after spray-inoculation with wild-type Pto
DC3000 (WT; inoculum: 106 cfu/mL), Pto DC3000 ΔhopU1 (inoculum: 108 cfu/mL)
and Pto DC3000 hrcC- (inoculum: 108 cfu/mL). Values are mean ± SE (n=4).
Statistical significance was assessed using the ANOVA test (P<0.05).
(G) Growth of Pseudomonas syringae pv. tomato (Pto) DC3000 wild-type and the
strain ΔhopU1 on Col-2 and the transgenic plants overexpressing GRP7 (GRP7ox),
as measured by colony forming units (cfu). Bacterial growth was measured four days
after spray-inoculation with wild-type DC3000 (WT; inoculum: 108 cfu/mL) and
DC3000 ΔhopU1 (inoculum: 108 cfu/mL). Values are mean ± SE (n=4). Statistical
significance was assessed using the ANOVA test (P<0.05).
All results shown are representative of at least three independent experiments.

Figure S3. GRP7 interacts with EFR at the plasma membrane.
(A) EFR and GRP7 interact in yeast two-hybrid assays. The cytoplasmic part of EFR
(EFRcyt) has been found to interact with GRP7 during a yeast two-hybrid screen and

2

confirmed upon expression of pLexA-EFRcyt and pB42AD-GRP7. Interaction assays
were performed in presence or absence of the auxotrophic amino acid leucine (Leu).
(B) Bimolecular fluorescence complementation assays between GRP7 and EFR.
YFPn, GRP7-YFPn, YFPc and EFR-YFPc, as well as the reverse combinations
YFPc, GRP7-YFPc, YFPn and EFR-YFPn, were transiently co-expressed in N.
benthamiana leaves. The chlorophyll autofluorescence appears in red. Scale bar
corresponds to 20 µm. Photographs were taken 2 days after infiltration and are
representative of the total observations (n=60).
All results shown are representative of three independent experiments.

Figure S4. GRP7 sub-cellular localisation.
(A) GRP7 sub-cellular localisation in the stable transgenic on Arabidopsis thaliana
plants 35S::GRP7-GFP line as observed by confocal microscopy. The chlorophyll
autofluorescence appears in red.
(B) Localisation of GRP7-eGFP transiently expressed in N. benthamiana and N.
tabacum as observed by confocal microscopy. The chlorophyll autofluorescence
appears in red.
All results shown are representative of three independent experiments.

Figure S5. HopU1 does not interact with, nor ADP-ribosylates FLS2 protein.
(A) Co-immunoprecipitation assay performed after transient co-expression of HopU1HA and FLS2-GFP-His on N. benthamiana plants, with (+) or without (-) treatment of
the samples with 1 µM flg22 during 15 min. Total proteins (input) were subjected to
immunoprecipitation with anti-HA beads followed by immunoblot analysis.
(B) Bimolecular fluorescence complementation assays between HopU1 and FLS2.
HopU1-YFPn and FLS2-YFPc, as well as the opposite combination HopU1-YFPc
and FLS2-YFPn, were transiently co-expressed N. benthamiana leaves. The
chlorophyll autofluorescence appears in red. Scale bar corresponds to 20 µm.
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Photographs were taken 2 days after infiltration and are representative of the total
observations (n=60).
(C) In vitro ADP-ribosylation assay performed with recombinant FLS2-GST and
HopU1-His on supernatant (sup.) and pellet (pell.) fractions. The reaction between
GRP7-GST and HopU1-His has been included as a positive control.
All results shown are representative of three independent experiments.

Figure S6. GRP7 interacts with HopU1 in the cytoplasm and in the nucleus.
(A) Co-immunoprecipitation of GRP7 and HopU1. GRP7-eGFP and HopU1-HA were
transiently co-expressed in N. benthamiana leaves. Total proteins (input) were
subjected to immunoprecipitation with anti-HA beads followed by immunoblot
analysis with anti-GFP antibodies to detect GRP7-eGFP.
(B) Bimolecular fluorescence complementation assays between GRP7 and HopU1.
GRP7-YFPn and HopU1-YFPc, as well as the opposite combination GRP7-YFPc
and HopU1-YFPn, were transiently co-expressed N. benthamiana leaves. The
chlorophyll autofluorescence appears in red. Scale bar corresponds to 20 µm.
Photographs were taken 2 days after infiltration and are representative of the total
observations (n=60).
All results shown are representative of three independent experiments.

Figure S7. HopU1 does not affect the elicitation-dependent dissociation of
eIF4E or S14 translational components from the GRP7 immunoprecipitates.
Co-immunoprecipitation assay performed on Col-0/GRP7-GFP plants expressing the
effector HopU1, untreated (-) or treated (+) with 1μM flg22 for 15 min. Total proteins
(input) were subjected to immunoprecipitation with GFP Trap beads followed by
immunoblot analysis with anti-GFP antibodies to detect GRP7-GFP or specific
antibodies recognizing the translation initiation factor elF4E or the ribosomal protein
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S14. Asterisks mark slower-migrating bands forms. The results shown are
representative of three independent experiments.

Figure S8. HopU1 disrupts GRP7-EFR transcripts interactions.
(A) RNA immunoprecipitation in HopU1-HA, GRP7-GFP and GRP7-GFP/HopU1-HA
Arabidopsis thaliana lines. Total proteins were subjected to immunoprecipitation with
GFP Trap beads followed by quantitative RT-PCR analysis of BAK1, EFR, and
GRP7 transcripts with specific primers. Values are mean ± SE (n=4).
(B) RNA immunoprecipitation in grp7, grp7/GRP7-HA and grp7/GRP7(R49K)-HA
Arabidopsis thaliana lines. Total proteins were subjected to immunoprecipitation with
anti-HA matrix beads followed by quantitative RT-PCR analysis of BAK1, EFR,
GRP7 and GRP8 transcripts with specific primers. Values are mean ± SE (n=4).

Figure S9. GRP8 also binds FLS2 and EFR transcripts.
RNA immunoprecipitation in Col-0 and GRP8-HA Arabidopsis thaliana lines. Total
proteins were subjected to immunoprecipitation with anti-HA beads followed by
quantitative RT-PCR analysis of BAK1, EFR, FLS2, GRP7 and GRP8 transcripts with
specific primers. Values are mean ± SE (n=4).

Figure S10. HopU1 does not affect BAK1 protein accumulation during
infection.
Immunoblots with specific antibodies detecting endogenous BAK1 or FLS2 in Col-0
during bacterial infection after syringe-inoculation with Pto DC3000 (WT; inoculum:
5x107 cfu/mL), Pto DC3000 ΔhopU1 (inoculum: 108 cfu/mL), Pto DC3000 hrcC(inoculum: 108 cfu/mL). hpi, hours post-infection; CBB, Coomassie Brillant Blue.
Values correspond to signal intensity of the FLS2-specific band from the
immunoblots relative to the zero time-point.
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Figure S11. GRP7 over-expression leads to increased FLS2 accumulation upon
flg22 treatment.
(A) Immunoblots with specific antibodies detecting endogenous FLS2 protein in Col-2
and the transgenic plants overexpressing GRP7 (GRP7ox), untreated (-) or treated
(+) with 1μM flg22 for 4 hours. CBB, Coomassie Brillant Blue.
(B) Quantification of FLS2 protein level in Col-2 and the transgenic plants
overexpressing GRP7 (GRP7ox), untreated (-) or treated (+) with 1 μM flg22 for 4
hours. The histogram represents the average of the FLS2 relative band intensity
compared to Col-0 (-) measured in three independent experiments. Values are mean
± SE (n=3). Statistical significance was assessed using the ANOVA test (P<0.05).
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Supplementary Table S1
Table

S1.

GRP7

interacting

proteins

identified

by

GRP7-HA

co-

immunoprecipitation.
Protein

Accession
number

GRP7:HA GRP7:HA GRP7:HA Col-0
Col-0
Col-0
Co-IP #1 Co-IP #2 Co-IP #3 Co-IP #1 Co-IP #2 Co-IP #3

GRP7

gi|15226605

68 (4030) 28 (1937) 84 (5247)

GRP8

gi|30692258

eEF1A
eIF4A1 or eIF4A2
chloroplast EF-Tu precursor

5 (140)

5 (119)

13 (162)

gi|295789
3 (85)
gi|79313227 or
4 (85)
gi|15221761
gi|23397095
8 (570)

6 (128)

5 (121)

2 (48)

2 (78)

2 (127)
1 (49)

11 (686)

12 (811)

2 (168)

ATMS1 (methionine synthase 1) gi|15238686

21 (749)

16 (465)

18 (801)

3 (57)

1 (100)

2 (165)

ATMS2 (methionine synthase 2) gi|15228634
gi|30688090 or
ATMS3 (methionine synthase 3)
gi|55670112
ATP synthase CF1 beta subunit
gi|7525040
(ATPB)
ATP synthase CF1 alpha
gi|7525018
subunit (ATPA)
peroxisomal glycolate oxidase gi|15231850

13 (560)

8 (247)

15 (651)

3 (614)

15 (443)

8 (407)

2 (39)

15 (614)

14 (663)

15 (727)

5 (264)

10 (494)

6 (163)

6 (253)

12 (470)

8 (399)

15 (710)

3 (48)

1 (65)

2 (58)
1 (45)

phosphoglycerate kinase

gi|1022805

9 (398)

4 (154)

10 (524)

3 (128)

2 (81)

Rubisco large subunit

gi|7525041

25 (849)

12 (408)

17 (519) 13 (451)

7 (226)

RCA (RUBISCO ACTIVASE)
GAPA (glyceraldehyde 3phosphate dehydrogenase A
subunit)
GAPA-2

gi|18405145

16 (534)

21 (717) 30 (1448) 3 (141)

4 (171)

16 (630)

gi|166702

13 (559)

12 (600)

5 (190)

3 (81)

3 (104)

gi|15222111

10 (532)

11 (587)

15 (719)

3 (72)

4 (138)

gi|336390
12 (439)
gi|15229231 or
9 (310)
GAPC1 or GAPC2
gi|15222848
HSP93-III
gi|186510816
gi|15222729 or
60 kDa Chaperonin or CPN60B
1 (62)
gi|15231255
PATL1 (PATELLIN 1);
gi|15218382
2 (57)
transporter
MTO3 (methionine overgi|15229033
accumulator 3)
transketolase-like protein
gi|7329685
14 (557)

15 (715)

20 (766)

7 (278)

2 (45)

6 (270)

10 (302)

10 (361)

2 (92)

2 (111)

2 (97)

10 (287)

6 (221)

1 (60)

4 (74)

1 (34)

1 (43)

1 (67)

1 (66)

1 (96)

4 (110)

GAPB

ACTIN 1*

gi|166582

2 (114)

ACTIN 7*

gi|15242516

2 (60)

ACTIN 8*

gi|1669389

2 (60)

myosin heavy chain-related
putative alanine
aminotransferase
GS2 (GLUTAMINE
SYNTHETASE 2)
AGT (ALANINE:GLYOXYLATE
AMINOTRANSFERASE)

15 (653)

5 (113)

1 (67)

7 (243)
2 (82)

5 (178)

gi|15238179

1 (35)

1 (36)

gi|13430566

2 (41)

2 (92)

gi|15238559

2 (66)

4 (147)

gi|15225026

1 (82)

1 (39)

GRP7 interacting proteins were isolated from transgenic GRP7-HA plants using anti-HA beads, and
identified with tandem mass spectrometry. Listed are all peptides present specifically in the GRP7-HA
plants compared to the Col-0 control plants, identified at least twice in three independent experiments
(probability of 95% or higher, equivalent to ion score of 32 or higher based on Mascot program). For
each identified protein, the number of peptides is listed. The ion scores are listed in the parenthesis.
*The actin sequences can be shared with other actin isoforms with equal or less probability.
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